PAREXEL International (PRXL) Given News Sentiment Score of 0.07
Headlines about PAREXEL International (NASDAQ:PRXL) have been trending somewhat positive on Saturday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PAREXEL International earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned media stories about the medical research company an impact score of 45.8601049261556 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Separately, Zacks Investment Research raised shares of PAREXEL International from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a research report on Thursday, August 31st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company. PAREXEL International presently has a consensus rating of “Hold” and a consensus target price of $80.76.
PAREXEL International (NASDAQ:PRXL) remained flat at $$88.08 on Friday. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.45 and a current ratio of 1.45. PAREXEL International has a 1 year low of $51.16 and a 1 year high of $88.10.
TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.watchlistnews.com/parexel-international-prxl-given-news-sentiment-score-of-0-07/1768162.html.
About PAREXEL International
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.
Receive News & Ratings for PAREXEL International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International and related companies with Analyst Ratings Network's FREE daily email newsletter.